Germany, Oct. 29 -- Evonik has won this year's CPHI Excellence in Pharma Award in the category "Finished Formulation". The winning innovation is EUDRACAP(R) colon - the first ready-to-fill, functional capsule on the market to target the ileo-colonic region. This functional capsule enables the development of new breakthrough oral drugs that use novel APIs, while accelerating the drug development process. EUDRACAP(R) colon is available produced under good manufacturing practice (GMP) for clinical and commercial use. EUDRACAP(R) colon was developed to enable the safe and effective oral delivery of sensitive active pharmaceutical ingredients (APIs) - such as live biotherapeutic products (LBPs), RNA, and biologics. These actives are used in the ...